GDF15 mediates the effects of metformin on body weight and energy balance
Metformin, the world’s most prescribed anti-diabetic drug, is also effective in preventing type 2 diabetes in people at high risk1,2. More than 60% of this effect is attributable to the ability of metformin to lower body weight in a sustained manner3. The molecular mechanisms by which metformin lowe...
Príomhchruthaitheoirí: | Coll, A, Chen, M, Taskar, P, Preiss, D, et al. |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Nature Research
2019
|
Míreanna comhchosúla
Míreanna comhchosúla
-
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
de réir: Jing Ouyang, et al.
Foilsithe / Cruthaithe: (2020-11-01) -
The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15
de réir: John W. R. Kincaid, et al.
Foilsithe / Cruthaithe: (2024-01-01) -
Research progress on the role and mechanism of GDF15 in body weight regulation
de réir: Xiao-Chen Dong, et al.
Foilsithe / Cruthaithe: (2023-11-01) -
Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation
de réir: Ella Fung, et al.
Foilsithe / Cruthaithe: (2021-04-01) -
SCAP Mediated GDF15-Induced Invasion and EMT of Esophageal Cancer
de réir: Gang Dong, et al.
Foilsithe / Cruthaithe: (2020-10-01)